| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $79.9M | +22.1% |
| Cost of Revenue | $20.8M | +20.4% |
| Gross Profit | $59.1M | +22.8% |
| R&D Expense | $23.7M | +13.8% |
| SG&A Expense | $57.1M | +4.7% |
| Operating Income | -$21.7M | +20.3% |
| Net Income | -$27.1M | +17.6% |
| EPS (Basic) | -$0.93 | +26.8% |
| EPS (Diluted) | -$0.93 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | -25.6% |
| Short-term Investments | $39.3M | -18.7% |
| Accounts Receivable | $12.9M | +4.4% |
| Inventory | $13.4M | +19.3% |
| Current Assets | $81.3M | -12.3% |
| Total Assets | $94.6M | -12.1% |
| Current Liabilities | $15.2M | -6.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | +8.9% |
| Capital Expenditures | $306K | +76.9% |
| Investing Cash Flow | $9.0M | -60.9% |
| Financing Cash Flow | $4.3M | -46.8% |
| Free Cash Flow | -$18.3M | +8.1% |
| +26.8% |
| Long-term Debt |
| $59.5M |
| +4.5% |
| Total Liabilities | $86.6M | -0.4% |
| Stockholders' Equity | $8.0M | -61.2% |